Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome
نویسندگان
چکیده
منابع مشابه
Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
BACKGROUND The hepatorenal syndrome is a severe and well-known complication of end-stage liver disease, but its management is controversial. Recent reports have shown the efficacy of terlipressin therapy, a vasopressin analogue, in hepatorenal syndrome patients. AIM To evaluate the efficacy and safety of terlipressin in the treatment of hepatorenal syndrome. METHODS We performed a systemati...
متن کاملNoradrenaline or terlipressin for hepatorenal syndrome?
Hepatorenal syndrome is a condition associated with very high mortality that may be reverted in some cases with vasoconstrictors. Terlipressin has generally been considered standard treatment, but noradrenaline has been postulated as alternative. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including four pertinent rand...
متن کاملTerlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
BACKGROUND Hepatorenal syndrome (HRS) is a severe complication of end-stage renal disease whose management still constitutes a big challenge. Various approaches have been used for hepatorenal syndrome treatment, including vasoconstrictor therapy. Terlipressin, a vasopressin analogue, has frequently been used. AIM To evaluate the efficacy and safety of terlipressin in patients with HRS by perf...
متن کاملTerlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives
Type 1 hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Type 1 HRS develops as the consequence of a severe reduction of effective circulating volume due to both extreme splanchnic arterial vasodilatation and reduction of cardiac output. Several pilot studies and two randomized control studies have shown that terlipressin plus alb...
متن کاملA randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.
BACKGROUND & AIMS Hepatorenal syndrome (HRS) type 1 is a progressive functional renal failure in subjects with advanced liver disease. The aim of this study was to evaluate the efficacy and safety of terlipressin, a systemic arterial vasoconstrictor, for cirrhosis type 1 HRS. METHODS A prospective, randomized, double-blind, placebo-controlled clinical trial of terlipressin was performed. Subj...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
سال: 2018
ISSN: 2249-782X
DOI: 10.7860/jcdr/2018/30817.11281